• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Liver cirrhosis and cardiovascular system].

作者信息

Ponte E, Cafagna D

机构信息

Cattedra di Angiologia, Università degli Studi, Trieste.

出版信息

Minerva Med. 1996 Jun;87(6):299-310.

PMID:8700359
Abstract

The patient with hepatocellular disease shows marked vasodilatation, accompanied by hyperdynamic circulation and opening of arteriovenous shunts. The effect of these circulatory changes and especially the profound vasodilation has only recently been investigated in detail. In patients with hepatocellular failure the extremities are flushed, the pulses bounding, the cardiac output increased and the blood pressure low. The circulation resembles what found with systemic arteriovenous fistulae. The peripheral vasodilatation and splanchnic venous pooling reduce the effective blood volume so activating baroreceptors. The secondary events which follow the vasodilation include stimulation of the sympathetic nervous system. This serves to counteract the tendency to arterial hypotension and probably contributes to renal hypoperfusion and to the hepatorenal syndrome development. The nature of the concerned vasodilators remains speculative, but is likely to be multiple. Whatever its nature, the substance might be formed by the sick hepatocyte, fail to be inactivated by it or bypass it through intra- or extra-hepatic portal systemic shunts. In cirrhosis the cardiac index and reduced systemic vascular resistance correlate with the Child's grade of liver failure. This article provides an overview of the general vasodilatory state and its effects on various organs. The mechanisms and the different vasoactive substances that might be responsible are also discussed.

摘要

相似文献

1
[Liver cirrhosis and cardiovascular system].
Minerva Med. 1996 Jun;87(6):299-310.
2
Splanchnic and systemic vasodilatation: the patient.内脏和全身血管舒张:患者
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S266-71. doi: 10.1097/MCG.0b013e3181576d1a.
3
Cardiac involvement in liver cirrhosis.
Ann Ital Med Int. 1993 Oct-Dec;8(4):244-7.
4
Circulatory function and hepatorenal syndrome in cirrhosis.肝硬化中的循环功能与肝肾综合征
Hepatology. 2005 Aug;42(2):439-47. doi: 10.1002/hep.20766.
5
Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?综述文章:肝肾综合征的发病机制与病理生理学——是否存在预防的空间?
Aliment Pharmacol Ther. 2004 Sep;20 Suppl 3:31-41; discussion 42-3. doi: 10.1111/j.1365-2036.2004.02112.x.
6
[Systemic circulatory hyperkinetic syndrome in patients with cirrhosis. Relation with hepatocellular failure and portal hypertension].[肝硬化患者的全身循环性高动力综合征。与肝细胞功能衰竭和门静脉高压的关系]
Gastroenterol Clin Biol. 1984 Apr;8(4):321-4.
7
Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.肝硬化腹水及肝肾综合征的发病因素与临床要素
Ann Ital Med Int. 1999 Oct-Dec;14(4):264-84.
8
Hepatorenal syndrome.肝肾综合征
Clin Ter. 2004 Sep;155(9):375-89.
9
Hepatorenal syndrome.肝肾综合征
Forum (Genova). 1998 Jan-Mar;8(1):62-81.
10
Arterial hypertension and chronic liver disease.动脉高血压与慢性肝病
Minerva Med. 2005 Aug;96(4):233-46.